Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MK-6070 by Merck for Small-Cell Lung Cancer: Likelihood of Approval
MK-6070 is under clinical development by Merck and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData, Phase...
Data Insights
MK-6070 by Merck for Prostate Cancer: Likelihood of Approval
MK-6070 is under clinical development by Merck and currently in Phase II for Prostate Cancer. According to GlobalData, Phase II...